Taiwan’s goal of reducing cancer mortality by one-third by 2030 will require sustained investment, earlier intervention, and wider access to innovative treatments. At the 2026 Cancer Summit, healthcare leaders discussed how to maximize the Cancer Drugs Fund and bring care pathways closer to global standards.